Bioactive compounds from macroalgae in the new millennium: Implications for neurodegenerative diseases

Marine Drugs

Volumn 12, Issue 9, 2014, Pages 4934-4972

  Barbosa, Mariana ^a   Valentão, Patrícia ^a   Andrade, Paula B ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Alzheimer's; Cholinesterase; Macroalgae; Neurodegeneration; Neuroinflammation; Neuroprotection; Oxidative nitrosative damage; Parkinson's

Indexed keywords

2 PHLOROECKOL; 6,6' BIECKOL; 7 PHLOROECKOL; ADVANCED GLYCATION END PRODUCT; ALKALOID DERIVATIVE; CAULERPIN; DIECKOL; ECKOL; ECKSTOLONOL; EPITAONDIOL; FATTY ACID DERIVATIVE; FLORIDOSIDE; FUCOPHLORETHOL A; GLYCOSIDE; NEUROPROTECTIVE AGENT; PHENOL DERIVATIVE; PHLOROFUCOFUROECKOL; PHLOROFUCOFUROECKOL A; PHLOROGLUCINOL; PHLOROTANNIN; PIGMENT; RACEMOSIN A; RACEMOSIN B; SARGACHROMENOL; STEROL DERIVATIVE; TERPENE DERIVATIVE; TETRAFUCOL A; TRIFUCODIPHLORETHOL A; TRIPHLORETHOL A; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIOXIDANT;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CONNECTOME; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; MACROALGA; MOLECULAR MECHANICS; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW; ANIMAL; CHEMISTRY; MICROBIOLOGY; NEURODEGENERATIVE DISEASES; SEAWEED;

ANIMALS; ANTIOXIDANTS; HUMANS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; SEAWEED; WATER MICROBIOLOGY;

EID: 84908052503     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md12094934     Document Type: Review

References (166)

1. Kadam, S.U.; Tiwari, B.K.; O'Donnell, C.P. Application of novel extraction technologies for bioactives from marine algae. J. Agric. Food Chem. 2013, 61, 4667-4675.
2. Bergmann, W.; Feeney, R.J. Contributions to the study of marine products. XXXII. The nucleosides of sponges. I.1. J. Org. Chem. 1951, 16, 981-987.
3. Leal, M.C.; Puga, J.; Serôdio, J.; Gomes, N.C.M.; Calado, R. Trends in the discovery of new marine natural products from invertebrates over the last two decades - where and what are we bioprospecting? PLoS One 2012, 7, e30580.
4. Heffernan, N.; Smyth, T.J.; FitzGerald, R.J.; Soler-Vila, A.; Brunton, N. Antioxidant activity and phenolic content of pressurised liquid and solid-liquid extracts from four Irish origin macroalgae. Int. J. Food Sci. Technol. 2014, 7, 1765-1772.
5. Mohamed, S.; Hashim, S.N.; Rahman, H.A. Seaweeds: A sustainable functional food for complementary and alternative therapy. Trends Food Sci. Technol. 2012, 23, 83-96.
6. Gupta S.; Abu-Ghannam, N. Bioactive potential and possible health effects of edible brown seaweeds. Trends Food Sci. Technol. 2011, 22, 315-326.
7. McHugh, D.J. A guide to the seaweed industry. In FAO Fisheries Technical Paper No. 441; Food and Agriculture Organization of the United Nations: Rome, Italy, 2003; pp. 1-105.
8. Smit, A.J. Medicinal and pharmaceutical uses of seaweed natural products: A review. J. Appl. Phycol. 2004, 16, 245-262.
9. Andrade, P.B.; Barbosa, M.; Matos, R.P.; Lopes, G.; Vinholes, J.; Mouga, T.; Valentão, P. Valuable compounds in macroalgae extracts. Food Chem. 2013, 138, 1819-1828.
10. Christaki, E.; Bonos, E.; Giannenas, I.; Florou-Paneri, P. Functional properties of carotenoids originating from algae. J. Sci. Food Agric. 2013, 93, 5-11.
11. Lordan, S.; Ross, R.P.; Stanton, C. Marine bioactives as functional food ingredients: Potential to reduce the incidence of chronic diseases. Mar. Drugs 2011, 9, 1056-1100.
12. Kang, M.-C.; Wijesinghe, W.A.J.P.; Lee, S.-H.; Kang, S.-M.; Ko, S.-C.; Yang, X.; Kang, N.; Jeon, B.-T.; Kim, J.; Lee, D.-H.; et al. Dieckol isolated from brown seaweed Ecklonia cava attenuates type II diabetes in db/db mouse model. Food Chem. Toxicol. 2013, 53, 294-298.
13. Vairappan, C.S.; Kamada, T.; Lee, W.-W.; Jeon, Y.-J. Anti-inflammatory activity of halogenated secondary metabolites of Laurencia snackeyi (Weber-van Bosse) Masuda in LPS-stimulated RAW 264.7 macrophages. J. Appl. Phycol. 2013, 25, 1805-1813.
14. Rengarajan, T.; Rajendran, P.; Nandakumar, N.; Balasubramanian, M.; Nishigaki, I. Cancer preventive efficacy of marine carotenoid fucoxanthin: Cell cycle arrest and apoptosis. Nutrients 2013, 5, 4978-4989.
15. Ansari. J.A.; Siraj, A.; Inamdar, N.N. Pharmacotherapeutic approaches of Parkinson's disease. Int. J. Pharmacol. 2010, 6, 584-590.
16. Cho, S.; Kim, S.-K. Neuropharmacological properties of marine plants. In Marine Pharmacognosy: Trends and Applications; Kim, S.-K., Ed.; Taylor & Francis: Boca Raton, FL, USA, 2012; pp. 355-372.
17. Holden, M.; Kelly, C. Use of cholinesterase inhibitors in dementia. Adv. Psychiatr. Treat. 2002, 8, 89-96.
18. Alzheimer's Association. 2013 Alzheimer's disease facts and figures. Alzheimer's Dement. J. Alzheimer's Assoc. 2013, 2, 208-245.
19. Syad, A.N.; Shunmugiah, K.P.; Kasi, P.D. Assessment of anticholinesterase activity of Gelidiella aceros a: Implications for its therapeutic potential against Alzheimer's disease. Evid.-Based Complement. Altern. Med. 2012, 2012, 1-8.
20. Kang, I.-J.; Jang, B.G.; In, S.; Choi, B.; Kim, M.; Kim, M.-J. Phlorotannin-rich Ecklonia cava reduces the production of beta-amyloid by modulating alpha- and gamma-secretase expression and activity. Neuro Toxicol. 2013, 34, 16-24.
21. Chaudhuri, K.R.; Schapira, A.H.V. Non-motor symptoms of Parkinson's disease: Dopaminergic pathophysiology and treatment. Lancet Neurol. 2009, 8, 464-474.
22. Biundo, R.; Weis, L.; Facchini, S.; Formento-Dojot, P.; Vallelunga, A.; Pilleri, M.; Antonini, A. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Park. Relat. Disord. 2014, 20, 394-399.
23. Tansey, M.G.; Goldberg, M.S. Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 2010, 37, 510-518.
24. Esposito, E.; Cuzzocrea, S. New therapeutic strategy for Parkinson's and Alzheimer's disease. Curr. Med. Chem. 2010, 17, 2764-2774.
25. Lull, M.; Block, M. Microglial activation and chronic neurodegeneration. Neurotherapeutics 2010, 7, 354-365.
26. Smid, S.D.; Maag, J.L.; Musgrave, I.F. Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: From molecular to clinical. Food Funct. 2012, 3, 1242-1250.
27. Jung, W.-K.; Ahn, Y.-W.; Lee, S.-H.; Choi, Y.H.; Kim, S.-K.; Yea, S.S.; Choi, I.; Park, S.-G.; Seo, S.-K.; Lee, S.-W.; et al. Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-κB pathways. Food Chem. Toxicol. 2009, 47, 410-417.
28. Heneka, M.T.; O'Banion, M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 2007, 184, 69-91.
29. Jung, W.-K.; Heo, S.-J.; Jeon, Y.-J.; Lee, C.-M.; Park, Y.-M.; Byun, H.-G.; Choi, Y.H.; Park, S.-G.; Choi, I.-W. Inhibitory effects and molecular mechanism of dieckol isolated from marine brown alga on COX-2 and iNOS in microglial cells. J. Agric. Food Chem. 2009, 57, 4439-4446.
30. In't Veld, B.A.; Ruitenberg, A.; Hofman, A.; Launer, L.J.; van Duijn, C.M.; Stijnen, T.; Breteler, M.M.B.; Stricker, B.H.C. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N. Engl. J. Med. 2001, 345, 1515-1521.
31. Park, H.Y.; Han, M.H.; Park, C.; Jin, C.-Y.; Kim, G.-Y.; Choi, I.-W.; Kim, N.D.; Nam, T.-J.; Kwon, T.K.; Choi, Y.H. Anti-inflammatory effects of fucoidan through inhibition of NF-κB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells. Food Chem. Toxicol. 2011, 49, 1745-1752.
32. Kim, M.; Li, Y.X.; Dewapriya, P.; Ryu, B.; Kim, S.K. Floridoside suppresses pro-inflammatory responses by blocking MAPK signaling in activated microglia. Biochem. Mol. Biol. Rep. 2013, 46, 398-403.
33. Uttara, B.; Singh, A.V.; Zamboni, P.; Mahajan, R.T. Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7, 65-74.
34. Grosso, C.; Valentão, P.; Ferreres, F.; Andrade, P.B. The use of flavonoids in central nervous system disorders. Curr. Med. Chem. 2013, 20, 4694-4719.
35. 2-induced oxidative stress in murine hippocampal HT22 cells. Environ. Toxicol. Pharmacol. 2012, 34, 96-105.
36. Sabeena Farvin, K.H.; Jacobsen, C. Phenolic compounds and antioxidant activities of selected species of seaweeds from Danish coast. Food Chem. 2013, 138, 1670-1681.
37. Pangestuti, R.; Kim, S.-K. Neuroprotective effects of marine algae. Mar. Drugs 2011, 9, 803-818.
38. 2-induced oxidative stress in murine hippocampal neuronal cells, HT22. Appl. Biochem. Biotechnol. 2012, 166, 1520-1532.
39. Weinreb, O.; Amit, T.; Mandel, S.; Youdim, M.H. Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: A reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr. 2009, 4, 283-296.
40. Bohnen, N.I.; Albin, R.L. The cholinergic system and Parkinson disease. Behav. Brain Res. 2011, 221, 564-573.
41. Bazelyansky, M.; Robey, E.; Kirsch, J.F. Fractional diffusion-limited component of reactions catalyzed by acetylcholinesterase. Biochemistry 1986, 25, 125-130.
42. Greig, N.H.; Utsuki, T.; Ingram, D.K.; Wang, Y.; Pepeu, G.; Scali, C.; Yu, Q.-S.; Mamczarz, J.; Holloway, H.W.; Giordano, T.; et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent. Proc. Natl. Acad. Sci. USA 2005, 102, 17213-17218.
43. Terry, A.V.; Buccafusco, J.J. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 2003, 306, 821-827.
44. Suganthy, N.; Karutha Pandian, S.; Pandima Devi, K. Neuroprotective effect of seaweeds inhabiting South Indian coastal area (Hare Island, Gulf of Mannar Marine Biosphere Reserve): Cholinesterase inhibitory effect of Hypnea valentiae and Ulva reticulata. Neurosci. Lett. 2010, 468, 216-219.
45. Kang, I.-J.; Jeon, Y.E.; Yin, X.F.; Nam, J.-S.; You, S.G.; Hong, M.S.; Jang, B.G.; Kim, M.-J. Butanol extract of Ecklonia cava prevents production and aggregation of beta-amyloid, and reduces beta-amyloid mediated neuronal death. Food Chem. Toxicol. 2011, 49, 2252-2259.
46. Xu, P.-X.; Wang, S.-W.; Yu, X.-L.; Su, Y.-J.; Wang, T.; Zhou, W.-W.; Zhang, H.; Wang, Y.-J.; Liu, R.-T. Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation. Behav. Brain Res. 2014, 264, 173-180.
47. Butterfield, D.A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic. Res. 2002, 36, 1307-1313.
48. Pan, M.-H.; Lai, C.-S.; Ho, C.-T. Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 2010, 1, 15-31.
49. Thomas, N.V.; Kim, S.-K. Potential pharmacological applications of polyphenolic derivatives from marine brown algae. Environ. Toxicol. Pharmacol. 2011, 32, 325-335.
50. Lopes, G. Seaweeds from the Portuguese Coast: Chemistry, Antimicrobial and Anti-inflammatory Capacity. Ph.D. Thesis, Phytochemistry and Pharmacognosy Speciality, Faculty of Pharmacy, University of Porto, Porto, Portugal, January 2014.
51. Arnold, T.M.; Targett, N.M. Marine tannins: The importance of a mechanistic framework for predicting ecological roles. J. Chem. Ecol. 2002, 28, 1919-1934.
52. Lopes, G.; Sousa, C.; Silva, L.R.; Pinto, E.; Andrade, P.B.; Bernardo, J.; Mouga, T.; Valentão, P. Can phlorotannins purified extracts constitute a novel pharmacological alternative for microbial infections with associated inflammatory conditions? PLoS One 2012, 7, e31145.
53. Sathya, R.; Kanaga, N.; Sankar, P.; Jeeva, S. Antioxidant properties of phlorotannins from brown seaweed Cystoseira trinodis (Forsska˚l) C. Agardh. Arab. J. Chem. 2013, doi:10.1016/j.arabjc.2013.09.039.
54. Sugiura, Y.; Tanaka, R.; Katsuzaki, H.; Imai, K.; Matsushita, T. The anti-inflammatory effects of phlorotannins from Eisenia arborea on mouse ear edema by inflammatory inducers. J. Funct. Foods 2013, 5, 2019-2023.
55. Sugiura, Y.; Matsuda, K.; Okamoto, T.; Yamada, Y.; Imai, K.; Ito, T.; Kakinuma, M.; Amano, H. The inhibitory effects of components from a brown alga, Eisenia arborea, on degranulation of mast cells and eicosanoid synthesis. J. Funct. Foods 2009, 1, 387-393.
56. Eom, S.-H.; Kim, Y.-M.; Kim, S.-K. Antimicrobial effect of phlorotannins from marine brown algae. Food Chem. Toxicol. 2012, 50, 3251-3255.
57. Lee, J.; Kim, S.; Jung, W.-S.; Song, D.-G.; Um, B.-H.; Son, J.-K.; Pan, C.-H. Phlorofucofuroeckol-A, a potent inhibitor of aldo-keto reductase family 1 member B10, from the edible brown alga Eisenia bicyclis. J. Korean Soc. Appl. Biol. Chem. 2012, 55, 721-727.
58. Lee, S.-H.; Jeon, Y.-J. Anti-diabetic effects of brown algae derived phlorotannins, marine polyphenols through diverse mechanisms. Fitoterapia 2013, 86, 129-136.
59. Myung, C.-S.; Shin, H.-C.; Bao, H.; Yeo, S.; Lee, B.; Kang, J. Improvement of memory by dieckol and phlorofucofuroeckol in ethanol-treated mice: Possible involvement of the inhibition of acetylcholinesterase. Arch. Pharm. Res. 2005, 28, 691-698.
60. Yoon, N.Y.; Chung, H.Y.; Kim, H.R.; Choi, J.S. Acetyl- and butyrylcholinesterase inhibitory activities of sterols and phlorotannins from Ecklonia stolonifera. Fish. Sci. 2008, 74, 200-207.
61. Yoon, N.Y.; Lee, S.-H.; Yong, L.; Kim, S.-K. Phlorotannins from Ishige okamurae and their acetyl- and butyrylcholinesterase inhibitory effects. J. Funct. Foods 2009, 1, 331-335.
62. Ahn, B.R.; Moon, H.E.; Kim, H.R.; Jung, H.A.; Choi, J.S. Neuroprotective effect of edible brown alga Eisenia bicyclis on amyloid beta peptide-induced toxicity in PC12 cells. Arch. Pharm. Res. 2012, 35, 1989-1998.
63. 2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp. Neurol. 2003, 180, 144-155.
64. Li, Y.-X.; Kim, S.-K. Utilization of seaweed derived ingredients as potential antioxidants and functional ingredients in the food industry: An overview. Food Sci. Biotechnol. 2011, 20, 1461-1466.
65. Srikanth, V.; Maczurek, A.; Phan, T.; Steele, M.; Westcott, B.; Juskiw, D.; Münch, G. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. Neurobiol. Aging 2011, 32, 763-777.
66. Liu, H.; Gu, L. Phlorotannins from brown algae (Fucus vesiculosus) inhibited the formation of advanced glycation endproducts by scavenging reactive carbonyls. J. Agric. Food Chem. 2012, 60, 1326-1334.
67. Kannan, R.R.R.; Aderogba, M.A.; Ndhlala, A.R.; Stirk, W.A.; van Staden, J. Acetylcholinesterase inhibitory activity of phlorotannins isolated from the brown alga, Ecklonia maxima (Osbeck) Papenfuss. Food Res. Int. 2013, 54, 1250-1254.
68. Alghazeer, R.; Whida, F.; Abduelrhman, E.; Gammoudi, F.; Naili, M. In vitro antibacterial activity of alkaloid extracts from green, red and brown macroalgae from western coast of Libya. Afr. J. Biotechnol. 2013, 5, 7086-7091.
69. Güven, K.C.; Percot, A.; Sezik, E. Alkaloids in marine algae. Mar. Drugs 2010, 8, 269-284.
70. Güven, K.; Coban, B.; Sezik, E.; Erdugan, H.; Kaleaʇasioʇlu, F. Alkaloids of marine macroalgae. In Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes; Ramawat, K.G., Mérillon, J.-M., Eds.; Springer (Berlin Heidelberg): Berlin, Germany, 2013; pp. 25-37.
71. Kaleaʇasioʇlu, F.; Güven, K.; Sezik, E.; Erdugan, H.; Coban, B. Pharmacology of macroalgae alkaloids. In Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes; Ramawat, K.G., Mérillon, J.-M., Eds.; Springer Berlin Heidelberg: Berlin, Germany, 2013; pp. 1203-1216.
72. Liu, D.-Q.; Mao, S.-C.; Yu, X.-Q.; Feng, L.-H.; Lai, X.-P. Caulerchlorin, a novel chlorinated bisindole alkaloid with antifungal activity from the Chinese green alga Caulerpa racemosa. Heterocycles 2012, 85, 661-666.
73. Liu, D.-Q.; Mao, S.-C.; Zhang, H.-Y.; Yu, X.-Q.; Feng, M.-T.; Wang, B.; Feng, L.-H.; Guo, Y.-W. Racemosins A and B, two novel bisindole alkaloids from the green alga Caulerpa racemosa. Fitoterapia 2013, 91, 15-20.
74. De Souza, É.T.; Pereira de Lira, D.; Cavalcanti de Queiroz, A.; Costa da Silva, D.J.; Bezerra de Aquino, A.; Campessato Mella, E.; Prates Lorenzo, V.; de Miranda, G.E.; de Araújo-Júnior, J.X.; de Oliveira Chaves, M.C.; et al. The antinociceptive and anti-inflammatory activities of caulerpin, a bisindole alkaloid isolated from seaweeds of the genus Caulerpa. Mar. Drugs 2009, 7, 689-704.
75. Miglio, G.; Varsaldi, F.; Francioli, E.; Battaglia, A.; Canonico, P.L.; Lombardi, G. Cabergoline protects SH-SY5Y neuronal cells in an in vitro model of ischemia. Eur. J. Pharmacol. 2004, 489, 157-165.
76. Grosso, C.; Vinholes, J.; Valentão, P.; Andrade, P.B. Halogenated compounds from seaweed, a biological overview. In Seaweed: Ecology, Nutrient Composition and Medicinal Uses; Pomin, V.H., Ed.; Nova Science Publishers, Incorporated: New York, NY, USA, 2011; pp. 163-184.
77. De las Heras, B.; Hortelano, S. Molecular basis of the anti-inflammatory effects of terpenoids. Inflamm. Allergy - Drug Targets 2009, 8, 28-39.
78. Gross, H.; König, G.M. Terpenoids from marine organisms: Unique structures and their pharmacological potential. Phytochem. Rev. 2006, 11, 115-141.
79. Brahmkshatriya, P.P.; Brahmkshatriya, P.S. Terpenes: Chemistry, biological role, and therapeutic applications. In Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes; Ramawat, K.G., Mérillon, J.-M., Eds.; Springer (Berlin Heidelberg): Berlin, Germany, 2013; pp. 2665-2691.
80. Wang, G.; Tang, W.; Bidigare, R. Terpenoids as therapeutic drugs and pharmaceutical agents. In Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes; Zhang, L., Demain, A., Eds.; Humana Press: New York, NY, USA, 2005; pp. 197-227.
81. Tsang, C.K.; Ina, A.; Goto, T.; Kamei, Y. Sargachromenol, a novel nerve growth factor-potentiating substance isolated from Sargassum macrocarpum, promotes neurite outgrowth and survival via distinct signaling pathways in PC12D cells. Neuroscience 2005, 132, 633-643.
82. Connor, B.; Dragunow, M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Rev. 1998, 27, 1-39.
83. Heese, K.; Low, J.W.; Inoue, N. Nerve growth factor, neural stem cells and Alzheimer's disease. Neuro-Signals 2006, 15, 1-12.
84. Kamei, Y.; Tsang, C.K. Sargaquinoic acid promotes neurite outgrowth via protein kinase A and MAP kinases-mediated signaling pathways in PC12D cells. Int. J. Dev. Neurosci. 2003, 21, 255-262.
85. Tsang, C.K.; Kamei, Y. Sargaquinoic acid supports the survival of neuronal PC12D cells in a nerve growth factor-independent manner. Eur. J. Pharmacol. 2004, 488, 11-18.
86. Klegeris, A.; McGeer, E.G.; McGeer, P.L. Therapeutic approaches to inflammation in neurodegenerative disease. Curr. Opin. Neurol. 2007, 20, 351-357.
87. Choi, B.W.; Ryu, G.; Park, S.H.; Kim, E.S.; Shin, J.; Roh, S.S.; Shin, H.C.; Lee, B.H. Anticholinesterase activity of plastoquinones from Sargassum sagamianum: Lead compounds for Alzheimer's disease therapy. Phytother. Res. 2007, 21, 423-426.
88. D'Orazio, N.; Gammone, M.A.; Gemello, E.; de Girolamo, M.; Cusenza, S.; Riccioni, G. Marine bioactives: Pharmacological properties and potential applications against inflammatory diseases. Mar. Drugs 2012, 10, 812-833.
89. Ryu, G.; Park, S.H.; Kim, E.S.; Choi, B.W.; Ryu, S.Y.; Lee, B.H. Cholinesterase inhibitory activity of two farnesylacetone derivatives from the brown alga Sargassum sagamianum. Arch. Pharm. Res. 2003, 26, 796-799.
90. Cengiz, S.; Cavas, L.; Yurdakoc, K.; Pohnert, G. The sesquiterpene caulerpenyne from Caulerpa spp. is a lipoxygenase inhibitor. Mar. Biotechnol. 2011, 13, 321-326.
91. Manev, H.; Chen, H.; Dzitoyeva, S.; Manev, R. Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2011, 35, 315-319.
92. Chu, J.; Praticò, D. Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model: Involvement of γ-secretase. Am. J. Pathol. 2011, 178, 1762-1769.
93. Ikonomovic, M.D.; Abrahamson, E.E.; Uz, T.; Manev, H.; DeKosky, S.T. Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease. J. Histochem. Cytochem. 2008, 56, 1065-1073.
94. Chang, H.-J.; Kim, H.J.; Chun, H.S. Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids. Life Sci. 2007, 80, 835-841.
95. Pangestuti, R.; Kim, S.-K. Biological activities and health benefit effects of natural pigments derived from marine algae. J. Funct. Foods 2011, 3, 255-266.
96. Kumari, P.; Kumar, M.; Reddy, C.R.K.; Jha, B. Algal lipids, fatty acids and sterols. In Functional Ingedients from Algae for Foods and Nutraceuticals; Domínguez, H., Ed.; Woodhead Publishing Limited: Cambridge, UK, 2013; pp. 87-134.
97. Zorofchian Moghadamtousi, S.; Karimian, H.; Khanabdali, R.; Razavi, M.; Firoozinia, M.; Zandi, K.; Abdul Kadir, H. Anticancer and antitumor potential of fucoidan and fucoxanthin, two main metabolites isolated from brown algae. Sci. World J. 2014, 2014, 1-10.
98. Ikeda, K.; Kitamura, A.; Machida, H.; Watanabe, M.; Negishi, H.; Hiraoka, J.; Nakano, T. Effect of Undaria pinnatifida (Wakame) on the development of cerebrovascular diseases in stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2003, 30, 44-48.
99. Sachindra, N.M.; Sato, E.; Maeda, H.; Hosokawa, M.; Niwano, Y.; Kohno, M.; Miyashita, K. Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. J. Agric. Food Chem. 2007, 55, 8516-8522.
100. Peng, J.; Yuan, J.-P.; Wu, C.-F.; Wang, J.-H. Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: Metabolism and bioactivities relevant to human health. Mar. Drugs 2011, 9, 1806-1828.
101. Heo, S.-J.; Ko, S.-C.; Kang, S.-M.; Kang, H.-S.; Kim, J.-P.; Kim, S.-H.; Lee, K.-W.; Cho, M.-G.; Jeon, Y.-J. Cytoprotective effect of fucoxanthin isolated from brown algae Sargassum siliquastrum against H2 O2-induced cell damage. Eur. Food Res. Technol. 2008, 228, 145-151.
102. Pangestuti, R.; Vo, T.-S.; Ngo, D.-H.; Kim, S.-K. Fucoxanthin ameliorates inflammation and oxidative responses in microglia. J. Agric. Food Chem. 2013, 61, 3876-3883.
103. Ambati, R.R.; Moi, P.S.; Ravi, S.; Aswathanarayana, R.G. Astaxanthin: Sources, extraction, stability, biological activities and its commercial applications - A review. Mar. Drugs 2014, 12, 128-152.
104. Choi, S.K.; Park, Y.S.; Choi, D.K.; Chang, H.I. Effects of astaxanthin on the production of NO and the expression of COX-2 and iNOS in LPS-stimulated BV2 microglial cells. J. Microbiol. Biotechnol. 2008, 18, 1990-1996.
105. Grosso, C.; Valentão, P.; Ferreres, F.; Andrade, P.B. Bioactive marine drugs and marine biomaterials for brain diseases. Mar. Drugs 2014, 12, 2539-2589.
106. Ikeda, Y.; Tsuji, S.; Satoh, A.; Ishikura, M.; Shirasawa, T.; Shimizu, T. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J. Neurochem. 2008, 107, 1730-1740.
107. 2-induced neurotoxicity in vitro and on focal cerebral ischemia in vivo. Brain Res. 2010, 1360, 40-48.
108. Lee, D.-H.; Lee, Y.J.; Kwon, K.H. Neuroprotective effects of astaxanthin in oxygen-glucose deprivation in SH-SY5Y cells and global cerebral ischemia in rat. J. Clin. Biochem. Nutr. 2010, 47, 121-129.
109. Kim, Y.H.; Koh, H.K.; Kim, D.S. Down-regulation of IL-6 production by astaxanthin via ERK-, MSK-, and NF-κB-mediated signals in activated microglia. Int. Immunopharmacol. 2010, 10, 1560-1572.
110. +-induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food Chem. Toxicol. 2011, 49, 271-280.
111. +-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway. Mar. Drugs 2013, 11, 1019-1034.
112. Ferruzzi, M.G.; Blakeslee, J. Digestion, absorption, and cancer preventative activity of dietary chlorophyll derivatives. Nutr. Res. 2007, 27, 1-12.
113. Ina, A.; Hayashi, K.-I.; Nozaki, H.; Kamei, Y. Pheophytin A, a low molecular weight compound found in the marine brown alga Sargassum fulvellum, promotes the differentiation of PC12 cells. Int. J. Dev. Neurosci. 2007, 25, 63-68.
114. Khodosevich, K.; Monyer, H. Signaling involved in neurite outgrowth of postnatally born subventricular zone neurons in vitro. BMC Neurosci. 2010, 11, 1-11.
115. Kurihara, H.; Kagawa, Y.; Konno, R.; Kim, S.M.; Takahashi, K. Lipoxygenase inhibitors derived from marine macroalgae. Bioorganic Med. Chem. Lett. 2014, 24, 1383-1385.
116. Ibañez, E.; Herrero, M.; Mendiola, J.; Castro-Puyana, M. Extraction and characterization of bioactive compounds with health benefits from marine resources: Macro and micro algae, cyanobacteria, and invertebrates. In Marine Bioactive Compounds: Sources, Characterization and Applications; Hayes, M., Ed.; Springer US: New York, NY, USA, 2012; pp. 55-98.
117. Romay, C.; González, R.; Ledón, N.; Remirez, D.; Rimbau, V. C-phycocyanin: A biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr. Protein Pept. Sci. 2003, 4, 207-216.
118. Bhat, V.B.; Madyastha, K.M. C-phycocyanin: A potent peroxyl radical scavenger in vivo and in vitro. Biochem. Biophys. Res. Commun. 2000, 275, 20-25.
119. Pinero Estrada, J.E.; Bermejo Bescos, P.; Villar del Fresno, A.M. Antioxidant activity of different fractions of Spirulina platensis protean extract. Il Farmaco 2001, 56, 497-500.
120. Riss, J.; Décordé, K.; Sutra, T.; Delage, M.; Baccou, J.C.; Jouy, N.; Brune, J.P.; Oreal, H.; Cristol, J.P.; Rouanet, J.M. Phycobiliprotein C-phycocyanin from Spirulina platensisis powerfully responsible for reducing oxidative stress and NADPH oxidase expression induced by an atherogenic diet in hamsters. J. Agric. Food Chem. 2007, 55, 7962-7967.
121. Bermejo, P.; Pinero, E.; Villar, A.M. Iron-chelating ability and antioxidant properties of phycocyanin isolated from a protean extract of Spirulina platensis. Food Chem. 2008, 110, 436-445.
122. Upasani, C.D.; Balaraman, R. Protective effect of Spirulina on lead induced deleterious changes in the lipid peroxidation and endogenous. Phytother. Res. 2003, 17, 330-334
123. Bermejo-Bescós, P.; Piñero-Estrada, E.; Villar del Fresno, Á.M. Neuroprotection by Spirulina platensis protean extract and phycocyanin against iron-induced toxicity in SH-SY5Y neuroblastoma cells. Toxicol. In Vitro 2008, 22, 1496-1502.
124. Pentón-Rol, G.; Marín-Prida, J.; Pardo-Andreu, G.; Martínez-Sánchez, G.; Acosta-Medina, E.F.; Valdivia-Acosta, A.; Lagumersindez-Denis, N.; Rodríguez-Jiménez, E.; Llópiz-Arzuaga, A.; López-Saura, P.A.; et al. C-Phycocyanin is neuroprotective against global cerebral ischemia/reperfusion injury in gerbils. Brain Res. Bull. 2011, 86, 42-52.
125. Moreau, R.A.; Whitaker, B.D.; Hicks, K.B. Phytosterols, phytostanols, and their conjugates in foods: Structural diversity, quantitative analysis, and health-promoting uses. Prog. Lipid Res. 2002, 41, 457-500.
126. Lopes, G.; Sousa, C.; Bernardo, J.; Andrade, P.B.; Valentão, P.; Ferreres, F.; Mouga, T. Sterol profiles in 18 macroalgae of the Portuguese coast. J. Phycol. 2011, 47, 1210-1218.
127. Schwender, J.; Gemünden, C.; Lichtenthaler, H.K. Chlorophyta exclusively use the 1-deoxyxylulose 5-phosphate/2-C-methylerythritol 4-phosphate pathway for the biosynthesis of isoprenoids. Planta 2001, 212, 416-423.
128. Lohr, M.; Schwender, J.; Polle, J.E.W. Isoprenoid biosynthesis in eukaryotic phototrophs: A spotlight on algae. Plant Sci. 2012, 185-186, 9-22.
129. Lopes, G.; Sousa, C.; Valentão, P.; Andrade, P.B. Sterols in algae and health. In Bioactive Compounds from Marine Foods; Hernández-Ledesma, B., Herrero, M., Eds.; John Wiley & Sons Ltd.: Oxford, UK, 2013; pp. 173-191.
130. Jhamandas, J.H.; Wie, M.B.; Harris, K.; MacTavish, D.; Kar, S. Fucoidan inhibits cellular and neurotoxic effects of β-amyloid (Aβ) in rat cholinergic basal forebrain neurons. Eur. J. Neurosci. 2005, 21, 2649-2659.
131. Cumashi, A.; Ushakova, N.A.; Preobrazhenskaya, M.E.; D'Incecco, A.; Piccoli, A.; Totani, L.; Tinari, N.; Morozevich, G.E.; Berman, A.E.; Bilan, M.I.; et al. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007, 17, 541-552.
132. Prokofjeva, M.; Imbs, T.; Shevchenko, N.; Spirin, P.; Horn, S.; Fehse, B.; Zvyagintseva, T.; Prassolov, V. Fucoidans as potential inhibitors of HIV-1. Mar. Drugs 2013, 11, 3000-3014.
133. Luo, D.; Zhang, Q.; Wang, H.; Cui, Y.; Sun, Z.; Yang, J.; Zheng, Y.; Jia, J.; Yu, F.; Wang, X.; et al. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Eur. J. Pharmacol. 2009, 617, 33-40.
134. Cui, Y.Q.; Zhang, L.J.; Zhang, T.; Luo, D.Z.; Jia, Y.J.; Guo, Z.X.; Zhang, Q.B.; Wang, X.; Wang, X.M. Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharide-activated primary microglia. Clin. Exp. Pharm. Physiol. 2009, 37, 422-428.
135. Cui, Y.-Q.; Jia, Y.-J.; Zhang, T.; Zhang, Q.-B.; Wang, X.-M. Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of pro-inflammatory mediators in primary microglia. CNS Neurosci. Ther. 2012, 18, 827-833.
136. 2-induced apoptosis in PC12 cells via activation of PI3K/Akt pathway. Cell. Mol. Neurobiol. 2012, 32, 523-529.
137. Yu, G.; Guan, H.; Ioanoviciu, A.S.; Sikkander, S.A.; Thanawiroon, C.; Tobacman, J.K.; Toida, T.; Linhardt, R.J. Structural studies on κ-carrageenan derived oligosaccharides. Carbohydr. Res. 2002, 337, 433-440.
138. Yuan, H.; Song, J.; Li, X.; Li, N.; Dai, J. Immunomodulation and antitumor activity of κ-carrageenan oligosaccharides. Cancer Lett. 2006, 243, 228-234.
139. Sun, T.; Tao, H.; Xie, J.; Zhang, S.; Xu, X. Degradation and antioxidant activity of κ-carrageenans. J. Appl. Polym. Sci. 2010, 117, 194-199.
140. Xu, L.; Yao, Z.; Wu, H.; Wang, F.; Zhang, S. The immune regulation of κ-carrageenan oligosaccharide and its desulfated derivatives on LPS-activated microglial cells. Neurochem. Int. 2012, 61, 689-696.
141. Yao, Z.-A.; Xu, L.; Wu, H.-G. Immunomodulatory function of κ-carrageenan oligosaccharides acting on LPS-activated microglial cells. Neurochem. Res. 2014, 39, 333-343.
142. Holdt, S.; Kraan, S. Bioactive compounds in seaweed: Functional food applications and legislation. J. Appl. Phycol. 2011, 23, 543-597.
143. Nobre, M.E.P.; Correia, A.O.; Borges, M.D.B.; Sampaio, T.M.A.; Chakraborty, S.A.; Gonc¸alves, D.D.O.; Brito, G.A.D.C.; Leal, L.K.A.M.; Felipe, C.F.B.; Lucetti, D.L.; et al. Eicosapentaenoic acid and docosahexaenoic acid exert anti-inflammatory and antinociceptive effects in rodents at low doses. Nutr. Res. 2013, 33, 422-433.
144. Calder, P.C. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83, 1505S-1519S.
145. Colombo, M.L.; RisÈ, P.; Giavarini, F.; Angelis, L.; Galli, C.; Bolis, C.L. Marine macroalgae as sources of polyunsaturated fatty acids. Plant Foods Hum. Nutr. 2006, 61, 64-69.
146. Youdim, K.A.; Martin, A.; Joseph, J.A. Essential fatty acids and the brain: Possible health implications. Int. J. Dev. Neurosci. 2000, 18, 383-399.
147. De Lau, L.M.; Bornebroek, M.; Witteman, J.C.; Hofman, A.; Koudstaal, P.J.; Breteler, M.M. Dietary fatty acids and the risk of Parkinson disease: The Rotterdam study. Neurology 2005, 64, 2040-2045.
148. Morris, M.C.; Evans, D.A.; Bienias, J.L.; Tangney, C.C.; Bennett, D.A.; Wilson, R.S.; Aggarwal, N.; Schneider, J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer Disease. Arch. Neurol. 2003, 60, 940-946.
149. Farooqui, A.A.; Horrocks, L.A. Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue. J. Mol. Neurosci. 2001, 16, 263-272.
150. Murthy, M.; Hamilton, J.; Greiner, R.S.; Moriguchi, T.; Salem, N., Jr.; Kim, H.-Y. Differential effects of n-3 fatty acid deficiency on phospholipid molecular species composition in the rat hippocampus. J. Lipid Res. 2002, 43, 611-617.
151. Tracy, L.M.; Bergqvist, F.; Ivanova, E.V.; Jacobsen, K.T.; Iverfeldt, K. Exposure to the saturated free fatty acid palmitate alters BV-2 microglia inflammatory response. J. Mol. Neurosci. 2013, 51, 805-812.
152. Nicolson, G.L. Lipid Replacement as an adjunct to therapy for chronic fatigue, anti-aging and restoration of mitochondrial function. J. Am. Nutraceutical Assoc. 2003, 6, 4-10.
153. Nicolson, G.L.; Ash, M.E. Lipid Replacement Therapy: A natural medicine approach to replacing damaged lipids in cellular membranes and organelles and restoring function. Biochim. Biophys. Acta 2014, 1838, 1657-1679.
154. Nicolson, G.L.; Ellithorpe, R. Lipid replacement and antioxidant nutritional therapy for restoring mitochondrial function and reducing fatigue in chronic fatigue syndrome and other fatiguing illnesses. J. Chronic Fatigue Syndr. 2006, 13, 57-68.
155. Silva, G.; Pereira, R.B.; Valentão, P.; Andrade, P.B.; Sousa, C. Distinct fatty acid profile of ten brown macroalgae. Rev. Bras. Farmacogn. 2013, 23, 608-613.
156. Schmid, M.; Guihéneuf, F.; Stengel, D. Fatty acid contents and profiles of 16 macroalgae collected from the Irish Coast at two seasons. J. Appl. Phycol. 2014, 26, 451-463.
157. Pereira, H.; Barreira, L.; Figueiredo, F.; Custódio, L.; Vizetto-Duarte, C.; Polo, C.; Rešek, E.; Engelen, A.; Varela, J. Polyunsaturated fatty acids of marine macroalgae: Potential for nutritional and pharmaceutical applications. Mar. Drugs 2012, 10, 1920-1935.
158. Kumari, P.; Kumar, M.; Gupta, V.; Reddy, C.R.K.; Jha, B. Tropical marine macroalgae as potential sources of nutritionally important PUFAs. Food Chem. 2010, 120, 749-757.
159. Ren, Y.; Houghton, P.; Hider, R.C. Relevant activities of extracts and constituents of animals used in traditional Chinese medicine for central nervous system effects associated with Alzheimer's disease. J. Pharm. Pharmacol. 2006, 58, 989-996.
160. Akbar, M.; Calderon, F.; Wen, Z.; Kim, H.-Y. Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival. Proc. Natl. Acad. Sci. USA 2005, 102, 10858-10863.
161. Rao, J.S.; Ertley, R.N.; Lee, H.J.; DeMar, J.C.J.; Arnold, J.T.; Rapoport, S.I.; Bazinet, R.P. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol. Psychiatry 2007, 12, 36-46.
162. Kim, H.Y.; Moon, H.S.; Cao, D.; Lee, J.; Kevala, K.; Jun, S.B.; Lovinger, D.M.; Akbar, M.; Huang, B.X. N-Docosahexaenoylethanolamide promotes development of hippocampal neurons. Biochem. J. 2011, 435, 327-336.
163. Mukherjee, P.K.; Marcheselli, V.L.; Serhan, C.N.; Bazan, N.G. Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA 2004, 101, 8491-8496.
164. Orr, S.K.; Palumbo, S.; Bosetti, F.; Mount, H.T.; Kang, J.X.; Greenwood, C.E.; Ma, D.W.L.; Serhan, C.N.; Bazinet, R.P. Unesterified docosahexaenoic acid is protective in neuroinflammation. J. Neurochem. 2013, 127, 378-393.
165. Chen, C.T.; Liu, Z.; Bazinet, R.P. Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: An intracerebroventricular study. J. Neurochem. 2011, 116, 363-373.
166. Reddy, C.R.K.; Jha, B.; Fujita, Y.; Ohno, M. Seaweed micropropagation techniques and their potentials: An overview. In Nineteenth International Seaweed Symposium; Borowitzka, M.A., Critchley, A.T., Kraan, S., Peters, A., Sjøtum, K., Notoya, M., Eds.; Springer (Netherlands): Dordrecht, The Netherlands, 2009; Volume 2, pp. 159-167.